1. Synthesis of biologically-active reduced graphene oxide by using fucoidan as a multifunctional agent for combination cancer therapy.
- Author
-
Kang S, Hong YL, Ku BC, Lee S, Ryu S, Min DH, Jang H, and Kim YK
- Subjects
- Antibiotics, Antineoplastic pharmacology, Antineoplastic Agents chemistry, Combined Modality Therapy methods, Doxorubicin chemistry, Doxorubicin pharmacology, Drug Carriers chemistry, Drug Liberation, Graphite chemistry, HEK293 Cells, HeLa Cells, Humans, Hyperthermia, Induced methods, Infrared Rays, Oxidation-Reduction, Oxides chemistry, Oxides pharmacology, Polysaccharides chemistry, Reducing Agents chemistry, Reducing Agents pharmacology, Antineoplastic Agents pharmacology, Drug Carriers pharmacology, Graphite pharmacology, Neoplasms therapy, Polysaccharides pharmacology
- Abstract
A therapeutic reduced graphene oxide (RGO) is synthesized by using fucoidan (Fu) as the reducing and surface functionalizing agent. The synthesized Fu-RGO exhibits promising characteristics for therapeutic applications such as high dispersity in aqueous media, biocompatibility, selective cytotoxicity to cancer cells, high loading capacity of the anticancer drug, and photothermal conversion effect. Therefore, Fu-GO is successfully harnessed as a combinatorial cancer treatment platform through bio-functional (Fu), chemo (doxorubicin (Dox)) and photothermal (RGO with near-infrared irradiation) modalities.
- Published
- 2018
- Full Text
- View/download PDF